Consensus Adicet Bio, Inc.

Equities

ACET

US0070021086

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.68 ^USD	-7.18%		-13.85%	-11.11%

Apr. 22	Adicet Bio, Inc. Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the ASGCT 27th Annual Meeting	CI
Mar. 26	North American Morning Briefing : Markets Steady -2-	DJ

Evolution of the average Target Price on Adicet Bio, Inc.

Price target over the last 5 years

History of analyst recommendation changes

97a8941a0aeea40be2.MfSCPrWAXWhT9lw1Q_sgRGO16IEfLmAO0xy9LDHk4gI.QsH6DczfZC0nuRtRDc1hMk6MkMJrZzhopl_vZXaTlFFBhrRWg9IqWwq8Kw~aa4f4ee08753085f06f0486bb71346a4

Analyst Recommendations on Adicet Bio, Inc.

JonesTrading Upgrades Adicet Bio to Buy From Hold, Price Target is $6	Feb. 14	MT
Wedbush Lowers Adicet Bio's PT to $5 From $17, Adjusts Model to Reflect More Focused Strategy; Retains Outperform Rating	Nov. 09	MT
HC Wainwright Adjusts Adicet Bio Price Target to $26 From $38, Maintains Buy Rating	23-08-11	MT
Guggenheim Downgrades Adicet Bio to Neutral From Buy	23-06-27	MT
JonesTrading Downgrades Adicet Bio to Hold From Buy	23-06-27	MT
JMP Securities Downgrades Adicet Bio to Market Perform From Market Outperform	23-06-27	MT
Wedbush Cuts Adicet Bio's Price Target to $17 From $30 to be Conservative as Focus Remains on Post CAR-T Setting; Keeps Outperform Rating	23-06-27	MT
JPMorgan Downgrades Adicet Bio to Neutral From Overweight, Adjusts Price Target to $6 From $20	23-06-01	MT
Wall Street Set to Open Higher as Investors Await Inflation Data, Fed Rate Decision in Coming Days	22-12-12	MT
HC Wainwright Raises Price Target on Adicet Bio to $38 From $34, Keeps Buy Rating	22-12-12	MT
US Futures Move Modestly Higher Monday Ahead of Inflation Data Tuesday, Fed Rate Decision Meeting Conclusion Wednesday	22-12-12	MT
Wedbush Raises Adicet Bio's Price Target to $30 From $25, Keeps Outperform Rating	22-11-11	MT
JPMorgan Starts Adicet Bio at Overweight With $23 Price Target	22-09-21	MT
Truist Securities Lowers Adicet Bio's Price Target to $27 From $30, Maintains Buy Rating	22-08-23	MT
SMBC Nikko Starts Adicet Bio at Outperform With $28 Price Target	22-03-31	MT
JMP Securities Adjusts Adicet Bio's Price Target to $21 From $30, Maintains Market Outperform Rating	22-03-17	MT
Truist Securities Initiates Adicet Bio at Buy with $30 Price Target	22-03-08	MT
Jefferies Initiates Adicet Bio at Buy With $27 Price Target	22-03-04	MT
Guggenheim Adjusts Adicet Bio PT to $33 From $22, Maintains Buy Rating	21-12-06	MT
ADICET BIO : BTIG Initiates Adicet Bio at Buy Rating With $34 Price Target	21-05-18	MT
ADICET BIO : JonesTrading Initiates Adicet Bio at Buy Rating With $33 Price Target	21-04-29	MT
ADICET BIO : HC Wainwright Initiates Adicet Bio at Buy Rating With $27 Price Target	21-04-23	MT
ADICET BIO : Canaccord Genuity Starts Adicet Bio at Buy With $28 Price Target	21-04-14	MT
ADICET BIO : Guggenheim Starts Adicet Bio at Buy With $22 Price Target	21-04-08	MT
ADICET BIO : B. Riley Starts Adicet Bio at Buy With $30 Price Target	20-11-04	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.68 USD

Average target price

9.6 USD

Spread / Average Target

+471.43%

High Price Target

19 USD

Spread / Highest target

+1,030.95%

Low Price Target

5 USD

Spread / Lowest Target

+197.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Adicet Bio, Inc.

JonesTrading Institutional Services
Wedbush
HC Wainwright
Guggenheim
JMP Securities
JPMorgan Chase
Truist Securities
SMBC Nikko
Jefferies & Co.
BTIG
Canaccord Genuity

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar